Company Profile
AngioDynamics Stock Price, News & Analysis
Company overview
Business overview
AngioDynamics is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, AngioDynamics is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
AngioDynamics follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, AngioDynamics sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Why the stock is moving
ANGO is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Future catalysts
AngioDynamics’s catalysts are NanoKnife and Auryon adoption, plus broader vascular and oncology procedural growth. The stock improves when the company shows its device portfolio is gaining real clinical traction.
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
AngioDynamics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Source: AngioDynamics
- 02
AngioDynamics to Report Fiscal 2026 Second Quarter Results on January 6, 2026
Source: AngioDynamics
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.